Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seliger

Showing results (11-20 of 977) with videos related to

Pageof 98
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 7, 2007
Introduction: array technology - an overviewHartmut Seliger
Cancer Immunology, Immunotherapy : CII|June 23, 2026
"Tumor Immunology Meets Oncology" (TIMO), 22 May-24 May 2025 in Brandenburg an der Havel, GermanyBarbara Seliger
Solid State Nuclear Magnetic Resonance|August 1, 1997
T1 rho in nuclear quadrupole resonance: a theoretical studyJ Seliger
Frontiers in Immunology|June 11, 2019
Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor ImmunityBarbara Seliger
Cancer Immunology, Immunotherapy : CII|November 13, 2024
"Tumor immunology meets oncology" (TIMO), 18 April-20 April 2024, in Brandenburg an der Havel, GermanyBarbara Seliger
Cancer Immunology, Immunotherapy : CII|November 29, 2011
Novel insights into the molecular mechanisms of HLA class I abnormalitiesBarbara Seliger
Journal of Immunotoxicology|May 1, 2009
Different regulation of MHC class I antigen processing components in human tumorsBarbara Seliger
Community Mental Health Journal|January 1, 1981
Community mental health center readiness to comply with Section 504 of the Rehabilitation ActJ Seliger
Frontiers in Immunology|September 27, 2019
The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment-ReviewBarbara Seliger
Journal of Immunotoxicology|February 1, 2014
The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factorsBarbara Seliger
Pageof 98

Showing results (11-20 of 977) with videos related to

Sort By:
Pageof 98
Methods in Molecular Biology (Clifton, N.J.)|November 7, 2007
Introduction: array technology - an overviewHartmut Seliger
Cancer Immunology, Immunotherapy : CII|June 23, 2026
"Tumor Immunology Meets Oncology" (TIMO), 22 May-24 May 2025 in Brandenburg an der Havel, GermanyBarbara Seliger
Solid State Nuclear Magnetic Resonance|August 1, 1997
T1 rho in nuclear quadrupole resonance: a theoretical studyJ Seliger
Frontiers in Immunology|June 11, 2019
Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor ImmunityBarbara Seliger
Cancer Immunology, Immunotherapy : CII|November 13, 2024
"Tumor immunology meets oncology" (TIMO), 18 April-20 April 2024, in Brandenburg an der Havel, GermanyBarbara Seliger
Cancer Immunology, Immunotherapy : CII|November 29, 2011
Novel insights into the molecular mechanisms of HLA class I abnormalitiesBarbara Seliger
Journal of Immunotoxicology|May 1, 2009
Different regulation of MHC class I antigen processing components in human tumorsBarbara Seliger
Community Mental Health Journal|January 1, 1981
Community mental health center readiness to comply with Section 504 of the Rehabilitation ActJ Seliger
Frontiers in Immunology|September 27, 2019
The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment-ReviewBarbara Seliger
Journal of Immunotoxicology|February 1, 2014
The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factorsBarbara Seliger
Pageof 98